RaySearch Laboratories AB (publ) (RSLBF)

Market Cap	491.50M -35.9%
Revenue (ttm)	133.47M +3.2%
Net Income	20.51M -6.6%
EPS	0.61 -5.8%
Shares Out	n/a
PE Ratio	27.43
Forward PE	23.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	16.85
Previous Close	20.00
Day's Range	16.85 - 16.85
52-Week Range	16.49 - 25.50
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2000
• Employees: 477
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSLBF

Financial Performance

In 2025, RaySearch Laboratories AB's revenue was 1.34 billion, an increase of 12.78% compared to the previous year's 1.19 billion. Earnings were 227.80 million, an increase of 11.94%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error